RCE Quarterly Activities/Appendix 4C Cash Flow Report 26/07/24 PRICE SENSITIVE download Created with Sketch. 926.64KB Share RCE US Department of Defense Grants US $2m for R327G 15/07/24 PRICE SENSITIVE download Created with Sketch. 346.08KB Share RCE R327 Efficacy against WHO Priority Pathogen Acinetobacter B 08/07/24 PRICE SENSITIVE download Created with Sketch. 504.85KB Share RCE Placement & SPP to raise $10 million - Funded to FY26 02/07/24 PRICE SENSITIVE download Created with Sketch. 299.88KB Share RCE Trading Halt 01/07/24 PRICE SENSITIVE download Created with Sketch. 565.47KB Share RCE Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete 28/06/24 PRICE SENSITIVE download Created with Sketch. 381.7KB Share RCE Ethics Approval Broadens to All Topical Infections 24/06/24 PRICE SENSITIVE download Created with Sketch. 345.82KB Share RCE Further R&D Rebate Approved 18/06/24 PRICE SENSITIVE download Created with Sketch. 224.3KB Share RCE R327 added to WHO List of Antibacterial Products 18/06/24 PRICE SENSITIVE download Created with Sketch. 565.63KB Share RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial 11/06/24 PRICE SENSITIVE download Created with Sketch. 262.74KB Share RCE Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort 15/05/24 PRICE SENSITIVE download Created with Sketch. 239.86KB Share RCE MCRI Pilot Study- Positive Efficacy Data for Lung Infections 09/05/24 PRICE SENSITIVE download Created with Sketch. 498KB Share RCE China Patent Granted for RECCE Anti-Infectives 07/05/24 PRICE SENSITIVE download Created with Sketch. 241.55KB Share RCE Safety Committee Approves High Dose of 4,000mg 26/04/24 PRICE SENSITIVE download Created with Sketch. 263.52KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 22/04/24 PRICE SENSITIVE download Created with Sketch. 575.83KB Share RCE Recce Completes 5,000 R327 Doses Per Week under GMP 16/04/24 PRICE SENSITIVE download Created with Sketch. 217.27KB Share RCE Recce Pharmaceuticals - Business Update 08/04/24 PRICE SENSITIVE download Created with Sketch. 582.67KB Share RCE Patent Granted in Israel for RECCE Anti-Infectives 03/04/24 PRICE SENSITIVE download Created with Sketch. 324.65KB Share RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial 15/03/24 PRICE SENSITIVE download Created with Sketch. 278.98KB Share RCE Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial 12/03/24 PRICE SENSITIVE download Created with Sketch. 262.97KB Share RCE Recce Receives AUD $11.17m R&D Advance 08/03/24 PRICE SENSITIVE download Created with Sketch. 238.07KB Share RCE Appendix 4D and Interim Financial Report 27/02/24 PRICE SENSITIVE download Created with Sketch. 464.55KB Share RCE Safety Committee Approves Expansion of Ph I/II DFI Trial 26/02/24 PRICE SENSITIVE download Created with Sketch. 246.18KB Share RCE RCE Establishes Strategic Partnership in South-East Asia 06/02/24 PRICE SENSITIVE download Created with Sketch. 451.89KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 30/01/24 PRICE SENSITIVE download Created with Sketch. 746.24KB Share RCE Positive Ph I/II DFI Efficacy Data to Support Site Expansion 18/01/24 PRICE SENSITIVE download Created with Sketch. 266.33KB Share RCE Murdoch Children's R327 Efficacy UTI in-vivo 28/12/23 PRICE SENSITIVE download Created with Sketch. 384.21KB Share RCE RCE Awarded Further $11.17m Advanced Overseas Finding 15/12/23 PRICE SENSITIVE download Created with Sketch. 382.33KB Share RCE RCE Awarded $43.7m AusIndustry Advanced Overseas Finding 14/12/23 PRICE SENSITIVE download Created with Sketch. 376.84KB Share RCE Murdoch Children's R327 Efficacy N.gonorrhoeae in-vivo 14/12/23 PRICE SENSITIVE download Created with Sketch. 375.27KB Share RCE Canadian Patent Granted for RECCE Anti-Infectives 23/11/23 PRICE SENSITIVE download Created with Sketch. 320.09KB Share RCE Subjects Dosed Over 15 mins in UTI/Urosepsis Clinical Trial 07/11/23 PRICE SENSITIVE download Created with Sketch. 230.98KB Share RCE Committee Approves Fast 15-Min Infusion in Ph I/II Urosepsis 24/10/23 PRICE SENSITIVE download Created with Sketch. 305.03KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 20/10/23 PRICE SENSITIVE download Created with Sketch. 1.02MB Share RCE Completes Cohort Dosing UTI/Urosepsis Rapid Infusion Trial 22/09/23 PRICE SENSITIVE download Created with Sketch. 268.92KB Share RCE Placement and Entitlement Offer 11/09/23 PRICE SENSITIVE download Created with Sketch. 276.98KB Share RCE Trading Halt 08/09/23 PRICE SENSITIVE download Created with Sketch. 317.42KB Share RCE Opening R&D Address at World AMR Congress 08/09/23 PRICE SENSITIVE download Created with Sketch. 3.23MB Share RCE RECCE Trademark Registered - Vietnam 06/09/23 PRICE SENSITIVE download Created with Sketch. 289.61KB Share RCE Additional Positive Patient Cases - Special Access Scheme 31/08/23 PRICE SENSITIVE download Created with Sketch. 497.11KB Share RCE Appendix 4E and Unaudited Preliminary Report 31/08/23 PRICE SENSITIVE download Created with Sketch. 503.53KB Share RCE Next Dose Cleared in Rapid Infusion Phase I/II UTI Trial 28/08/23 PRICE SENSITIVE download Created with Sketch. 256.66KB Share RCE Patients Dosed in R327 Diabetic Foot Infection Trial 22/08/23 PRICE SENSITIVE download Created with Sketch. 281.98KB Share RCE Phase I/II Burn Wound Infection Trial Stage 1 Complete 21/08/23 PRICE SENSITIVE download Created with Sketch. 349.53KB Share RCE Positive Patients Update - Special Access Scheme 08/08/23 PRICE SENSITIVE download Created with Sketch. 537.59KB Share RCE Australian Patent Granted for RECCE Anti-Infectives 03/08/23 PRICE SENSITIVE download Created with Sketch. 318.83KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 31/07/23 PRICE SENSITIVE download Created with Sketch. 480.05KB Share RCE Bonus Canadian R&D Rebate Received 28/07/23 PRICE SENSITIVE download Created with Sketch. 265.44KB Share RCE Scientia Completes Cohort Dosing in Phase I/II UTI Trial 28/07/23 PRICE SENSITIVE download Created with Sketch. 273.47KB Share RCE Scientia Doses Ahead of Schedule in Phase I/II UTI Trial 24/07/23 PRICE SENSITIVE download Created with Sketch. 273.72KB Share RCE Clarification - 5x Higher Concentration in Urine & Plasma 20/07/23 PRICE SENSITIVE download Created with Sketch. 168.73KB Share RCE Phase I Clinical Trial Data Review Complete 19/07/23 PRICE SENSITIVE download Created with Sketch. 631.65KB Share RCE A$801,604 R&D Rebate Advance Received 12/07/23 PRICE SENSITIVE download Created with Sketch. 223.17KB Share RCE First Cohort Dosed in Rapid Infusion Phase I/II UTI study 10/07/23 PRICE SENSITIVE download Created with Sketch. 266.1KB Share RCE Ethics Approval for Phase I/II UTI Trial Expansion 29/06/23 PRICE SENSITIVE download Created with Sketch. 280.54KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 710.13KB Share RCE Ethics Approval to Start Phase I/II (I.V.) Clinical Trial 17/04/23 PRICE SENSITIVE download Created with Sketch. 258.68KB Share RCE New Family 4 Patent to be Granted for RECCE Anti-Infectives 11/04/23 PRICE SENSITIVE download Created with Sketch. 272.7KB Share RCE Recce Receives Further A$973,144 R&D Advance 04/04/23 PRICE SENSITIVE download Created with Sketch. 220.97KB Share RCE Corporate Presentation - WI Emergence 2023 23/03/23 PRICE SENSITIVE download Created with Sketch. 2.82MB Share RCE Appendix 4D and Interim Financial Report 27/02/23 PRICE SENSITIVE download Created with Sketch. 312KB Share RCE Recce Selects CMAX for Phase I/II UTI Clinical Trial 20/02/23 PRICE SENSITIVE download Created with Sketch. 393.65KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 30/01/23 PRICE SENSITIVE download Created with Sketch. 613.04KB Share RCE A$6.21m Received from R&D Rebate Payments 25/01/23 PRICE SENSITIVE download Created with Sketch. 317.75KB Share RCE JP Morgan Healthcare Conference 10/01/23 PRICE SENSITIVE download Created with Sketch. 3.42MB Share RCE Australian Patent to be Granted for RECCE Anti-Infectives 10/01/23 PRICE SENSITIVE download Created with Sketch. 250.74KB Share RCE Anti-Infective Research Unit est. at Murdoch Children's 15/12/22 PRICE SENSITIVE download Created with Sketch. 319.96KB Share RCE Approval to Start Phase I/II Diabetic Foot Ulcer Study 09/12/22 PRICE SENSITIVE download Created with Sketch. 329.13KB Share RCE Trading Halt 07/12/22 PRICE SENSITIVE download Created with Sketch. 643.19KB Share RCE Pause in Trading 07/12/22 PRICE SENSITIVE download Created with Sketch. 113.49KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 28/10/22 PRICE SENSITIVE download Created with Sketch. 581.3KB Share RCE Anti-Infective Portfolio Update and Webinar details 19/10/22 PRICE SENSITIVE download Created with Sketch. 3.36MB Share RCE Pause in Trading 19/10/22 PRICE SENSITIVE download Created with Sketch. 115.99KB Share RCE R327 COVID Study Update 18/10/22 PRICE SENSITIVE download Created with Sketch. 398.4KB Share RCE Pause in trading 18/10/22 PRICE SENSITIVE download Created with Sketch. 115.68KB Share RCE Expansion and Acceleration of Clinical Programs 27/09/22 PRICE SENSITIVE download Created with Sketch. 308.99KB Share RCE Appendix 4E 31/08/22 PRICE SENSITIVE download Created with Sketch. 244.24KB Share RCE Phase I Clinical Trial of R327 I.V. - 6000mg Complete 22/08/22 PRICE SENSITIVE download Created with Sketch. 313.84KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 01/08/22 PRICE SENSITIVE download Created with Sketch. 944.67KB Share RCE Corporate Presentation - Aussie Equities Day 2022 28/07/22 PRICE SENSITIVE download Created with Sketch. 2.22MB Share RCE Phase I Positive Safety Data - 4000mg Complete 21/06/22 PRICE SENSITIVE download Created with Sketch. 241.36KB Share RCE Phase I Clinical Trial R327 Advances to 4000mg 20/05/22 PRICE SENSITIVE download Created with Sketch. 241.06KB Share RCE Corporate Presentation - Biotech Investor Lunch 16/05/22 PRICE SENSITIVE download Created with Sketch. 2.48MB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 02/05/22 PRICE SENSITIVE download Created with Sketch. 436.79KB Share RCE Phase I Clinical Trial R327 Advances to High Dose Cohort 12/04/22 PRICE SENSITIVE download Created with Sketch. 408.22KB Share RCE Anti-Viral Patent Granted in Hong Kong 11/04/22 PRICE SENSITIVE download Created with Sketch. 225.31KB Share RCE Positive safety data from 4th Cohort -Phase I Clinical Trial 30/03/22 PRICE SENSITIVE download Created with Sketch. 247.62KB Share RCE $3.08m R&D Rebate Received 28/03/22 PRICE SENSITIVE download Created with Sketch. 238.52KB Share RCE Safety Committee Clears PhI R327 Dose Increase 07/03/22 PRICE SENSITIVE download Created with Sketch. 265.52KB Share RCE S&P DJI Announces March 2022 Quarterly Rebalance 04/03/22 PRICE SENSITIVE download Created with Sketch. 175.5KB Share RCE Appendix 4D and Interim Financial Report 28/02/22 PRICE SENSITIVE download Created with Sketch. 265.76KB Share RCE Positive Safety Continues in 3rd Cohort PhI Clinical Trial 21/02/22 PRICE SENSITIVE download Created with Sketch. 266.79KB Share RCE Positive Safety Data from Third Cohort of PI Clinical Trial 08/02/22 PRICE SENSITIVE download Created with Sketch. 247.91KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 31/01/22 PRICE SENSITIVE download Created with Sketch. 441.2KB Share RCE Positive Safety Data from Second Cohort of PI Clinical Trial 18/01/22 PRICE SENSITIVE download Created with Sketch. 267.69KB Share RCE Positive Safety Data from Phase 1 Clinical Trial 07/01/22 PRICE SENSITIVE download Created with Sketch. 316.58KB Share RCE Patients to be Dosed in Ph 1 IV Clinical Trial of R327 15/12/21 PRICE SENSITIVE download Created with Sketch. 246.15KB Share RCE Update on Phase I/II Clinical Trial for Burn Wound Infection 07/12/21 PRICE SENSITIVE download Created with Sketch. 273.37KB Share RCE Opening R&D Address at World AMR Congress 08/11/21 PRICE SENSITIVE download Created with Sketch. 6.74MB Share RCE Appendix 4C and Activity Report 29/10/21 PRICE SENSITIVE download Created with Sketch. 413.29KB Share